Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Mar 30, 2026
Occidental Petroleum (OXY): +23% Surge in 30 Days and +59% Quarterly Gain Amid Oil Rally and Debt Cuts

Occidental Petroleum (OXY): +23% Surge in 30 Days and +59% Quarterly Gain Amid Oil Rally and Debt Cuts

Key Takeaways

  • OXY stock surged +23% over the last 30 days, propelled by rising oil prices amid Middle East tensions, analyst upgrades, and the OxyChem divestiture.
  • Over the past quarter, shares climbed +59%, driven by Q4 earnings beat, substantial debt reduction, and dividend increase.
  • Key factors include geopolitical oil price spikes, strategic balance sheet improvements, and positive analyst sentiment shifts.
  • Production records in the Permian Basin and operational efficiencies bolstered fundamentals amid sector tailwinds.
  • OxyChem sale proceeds slashed debt by $5.8 billion, enhancing financial flexibility.

Understanding Occidental Petroleum (OXY) and Its Market Position

Occidental Petroleum Corporation (OXY) stands out as a leading independent energy producer, with a primary focus on hydrocarbon exploration and production. The company has significant operations in the Permian Basin, one of the U.S.'s most productive oil regions, along with assets in the Rockies, Latin America, and the Middle East. Its business model emphasizes efficient drilling, low-cost production, and carbon capture initiatives aimed at long-term sustainability.

In the competitive oil and gas exploration and production (E&P) industry, OXY maintains a strong position thanks to its scale in the Permian, where it leverages economies of scale and technological edges in enhanced oil recovery. From what I see, the recent stock price movement reflects improving fundamentals like debt reduction and production growth, which position the company well amid rising commodity prices and market volatility.

OXY Stock Performance: 30-Day vs. Quarterly View

In the last 30 days, OXY stock moved from about $53 on February 27, 2026, to $65.32 on March 27, 2026, posting a +23% gain. The action was volatile and trend-driven, with sharp rallies linked to daily oil price jumps and news catalysts; shares hit near 52-week highs around $66 before some minor pullbacks on higher volume.

Looking at the past quarter, OXY climbed from roughly $41 at the end of December 2025 to $65.32, delivering a solid +59% rise. This showed consistent upward momentum that picked up steam in March, backed by above-average volume and broader energy sector trends.

Key Drivers Behind OXY's 30-Day Rally

One thing that stands out is how surging oil prices, fueled by Middle East geopolitical tensions, acted as a major tailwind—Brent crude topped $90 per barrel, and WTI approached $99 at peaks. This directly supports OXY's revenue prospects, especially with its Permian focus where breakeven costs stay under $50 per barrel.

Analyst upgrades added to the momentum, such as Wells Fargo's double upgrade to Overweight with a $69 target, JP Morgan moving to Neutral, and lifts from Citi, Morgan Stanley, and others. The $9.7 billion OxyChem sale to Berkshire Hathaway, which closed on January 2 with ongoing debt tender effects, cut principal debt by $5.8 billion to $15 billion, underscoring balance sheet progress. I also checked this using Tickeron’s AI Screener to gauge how OXY stacks up against industry peers.

Reports of CEO Vicki Hollub potentially stepping down, with COO Richard Jackson in line as successor, sparked some interest but were generally seen as positive in the context of refocusing on core E&P. These elements combined to fuel the uptrend.

Quarterly Performance Drivers for OXY

The quarter's +59% advance rested on foundations like Q4 2025 earnings, where adjusted EPS of $0.31 topped estimates even with revenue shortfalls, thanks to record production of 1.434 million barrels of oil equivalent per day (BOE/d) and strong Permian results.

Debt cuts from the OxyChem deal and continued tenders strengthened the leverage profile, while an 8.3% dividend increase to $0.26 per share signaled management confidence. Rising oil demand, institutional buying, and OXY's edge in the Permian during industry consolidation kept the gains going. In my view, macro tailwinds like oil's rebound from sub-$70 levels and geopolitical risks had the biggest overall impact, improving cash flow outlook.

Discovering Trending AI Robots for Your Trading

In my own research and trading, I often turn to Tickeron’s Trending AI Robots page, which spotlights the platform's top-performing AI trading bots out of hundreds managing thousands of tickers across markets. This section curates bots based on recent performance, relevance to current conditions, and strategy variety—from momentum and mean reversion to long-term trends. Each one shows metrics like win rate, average return, Sharpe ratio for risk-adjusted returns, and ideal timeframes, making it straightforward to match tools to your style and risk level. For something like energy volatility in OXY, these bots use machine learning for pattern spotting and execution. It's a practical way to add data-driven automation to my process.

What to Watch in OXY's Outlook

I'm watching upcoming Q1 2026 earnings closely for insights on Permian production growth and $500 million in cost savings goals. Oil price trajectories tied to geopolitics and global demand will be key, as will interest rate moves affecting capex.

Updates on debt tenders and CEO succession could sway sentiment, while carbon capture efforts like STRATOS and E&P regulations present potential catalysts. Risks to consider include oil price pullbacks or integration hurdles from acquisitions. Energy sector M&A trends deserve attention for competitive shifts. This is important because it shapes OXY's path forward.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.

Related Ticker: OXY

Contributor

Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.


OXY's RSI Oscillator peaks and leaves overbought zone

The 10-day RSI Indicator for OXY moved out of overbought territory on September 16, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 instances where the indicator moved out of the overbought zone. In 27 of the 34 cases the stock moved lower in the days that followed. This puts the odds of a move down at 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OXY as a result. In 56 of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.

The Moving Average Convergence Divergence Histogram (MACD) for OXY turned negative on September 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 25 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 57%.

OXY moved below its 50-day moving average on September 21, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for OXY crossed bearishly below the 50-day moving average on September 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 65%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OXY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +3.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where OXY advanced for three days, in 212 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.

OXY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 166 of 242 cases where OXY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 69%.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. OXY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 50 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 71, placing this stock slightly better than average.

The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.676) is normal, around the industry mean (5.088). P/E Ratio (16.549) is within average values for comparable stocks, (25.683). Projected Growth (PEG Ratio) (1.122) is also within normal values, averaging (1.958). Dividend Yield (0.019) settles around the average of (0.036) among similar stocks. P/S Ratio (2.497) is also within normal values, averaging (5.980).

The Tickeron PE Growth Rating for this company is 85 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are ConocoPhillips (NYSE:COP), Canadian Natural Resources Limited (NYSE:CNQ), EOG Resources (NYSE:EOG), Occidental Petroleum Corp (NYSE:OXY), Diamondback Energy (NASDAQ:FANG), Devon Energy Corp (NYSE:DVN), EQT Corp (NYSE:EQT), Expand Energy Corporation (NASDAQ:EXE), APA Corp (NASDAQ:APA), ANTERO RESOURCES Corp (NYSE:AR).

Industry description

The oil and gas production segment includes companies that specialize in exploration, development, and production of oil and natural gas. These companies are focused on upstream operations. Companies typically identify deposits, drill wells, and extract raw materials from underground. The industry also includes related services like rig operations, feasibility studies, machinery rentals etc. Several operators in this industry work with various types of contractors such as engineering procurement and construction contractors, as well as with joint-venture partners and oil field service companies. Oil and gas often involves large fixed costs of production; so, declining crude oil prices, for example, is a potential negative for this industry. Conoco Phillips, EOG Resources, Inc. and Pioneer Natural Resources Company are some examples of companies operating in this space.

Market Cap

The average market capitalization across the Oil & Gas Production Industry is 9.69B. The market cap for tickers in the group ranges from 100 to 151.42B. COP holds the highest valuation in this group at 151.42B. The lowest valued company is HKEB at 100.

High and low price notable news

The average weekly price growth across all stocks in the Oil & Gas Production Industry was -3%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was -10%. GLND experienced the highest price growth at 76%, while CRK experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the Oil & Gas Production Industry was -11%. For the same stocks of the Industry, the average monthly volume growth was 8% and the average quarterly volume growth was -57%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 50
Price Growth Rating: 54
SMR Rating: 71
Profit Risk Rating: 71
Seasonality Score: -8 (-100 ... +100)
View a ticker or compare two or three
OXY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry OilGasProduction

Industry
Oil And Gas Production
Address
5 Greenway Plaza
Phone
+1 713 215-7000
Employees
10412
Web
https://www.oxy.com
Interact to see
Advertisement
MRSH stock declined approximately -9% over the past 30 days, driven by sector-wide AI disruption fears and analyst downgrades. Over the past quarter, the stock fell around -7%, amid softening insurance rates and declining fiduciary interest income.
MCO stock declined approximately -9% over the last 30 days amid profit-taking, insider selling, and sector-wide concerns in financial data analytics. Over the past quarter, shares fell around -18%, reflecting a correction from January highs despite strong Q4 2025 earnings. Key drivers include post-earnings selloff after Q4 results, analyst price target cuts, and broader market volatility in credit ratings sector.
SNOW stock declined approximately -9% over the last 30 days, from around $168 to $153, amid post-earnings profit-taking and analyst caution despite strong results. Over the past quarter, the stock fell about -31%, from near $223, reflecting broader sector pressures and valuation concerns in cloud software.
WDS stock surged +24% over the past 30 days, driven by a sharp rally in oil and LNG prices amid Middle East supply disruptions, including Strait of Hormuz issues and strikes on Qatar's Ras Laffan facility. Over the past quarter, the stock climbed +55%, reflecting sustained energy market volatility and Woodside's strong production from assets like Sangomar and Pluto LNG.
HMC stock declined -19% over the past 30 days amid major setbacks in EV strategy, including cancellation of North American EV models and up to $15.7 billion in related losses. Over the past quarter, shares fell -18%, driven by persistent auto segment weakness, tariff impacts, and revised FY2026 forecasts to a net loss. Key catalysts include March EV reassessment announcement causing a 5%+ drop, Q3 earnings beat overshadowed by one-time charges and guidance concerns, and Sony-Honda JV EV project halt.
EL stock plunged approximately -39% over the past 30 days amid merger discussions with Puig, tariff pressures, and restructuring costs, marking a highly volatile period. Over the past quarter, the stock is down around -37%, reflecting broader sector headwinds despite earlier quarterly earnings beats. Key drivers include confirmation of potential business combination with Puig sparking uncertainty, ongoing $100 million tariff impacts, and elevated restructuring expenses.
ESLT stock rose +13% over the past 30 days, driven primarily by a blowout Q4 2025 earnings report with revenue up 11% and EPS beating estimates by over 10%. Over the past quarter, shares surged +52%, fueled by a record $28.1 billion order backlog, up significantly year-over-year, amid heightened global defense demand. Geopolitical tensions in the Middle East boosted demand for Elbit's systems, alongside major contract wins totaling hundreds of millions from international clients.
EQT stock rose approximately +10% over the last 30 days, driven by strong Q4 2025 earnings beat, robust free cash flow guidance for 2026, and analyst price target increases. Over the past quarter, shares gained around +23%, fueled by operational efficiencies, natural gas price recovery, and positive sector sentiment amid LNG demand growth.
Robin Energy Ltd is a Cyprus-based shipping company focused on ocean and deep-sea freight transportation. As a holding entity, it acquires, owns, charters, and manages oceangoing tanker vessels worldwide. The core of its business lies in energy transportation services, mainly through handysize tankers and LPG carriers. In the competitive marine shipping industry, RBNE positions itself as a growth-oriented player, expanding its fleet and locking in multi-year charters. Recent developments, such as vessel acquisitions and Bitcoin treasury allocations, leave it exposed to shipping cycles and alternative asset volatility. From what I see, this mix contributes to the erratic stock price behavior we've observed amid shifting global energy demand and freight rates.
NG stock plunged -42% over the past 30 days amid sharp declines from mid-March peaks around $14, driven by profit-taking after a multi-year rally and sector-wide weakness in gold mining stocks. Over the past quarter, the stock is down -14%, reflecting volatility from early-year gains tied to financing successes offset by recent macro pressures and permitting concerns. Key drivers include gold price fluctuations due to interest rate expectations, profit-taking post-240%+ annual surge, and no immediate production revenue despite Donlin Gold project advancements.
CRBU stock declined approximately -10% over the past 30 days, reflecting volatility amid clinical updates and financing concerns. Over the past quarter, the stock rose about +12%, driven by positive earnings beats and pipeline progress. Key drivers include Q4 2025 earnings beat, vispa-cel Phase 3 plans, but offset by cash burn and need for additional capital.
Shares of Viridian Therapeutics (VRDN) are down approximately 32% in premarket trading on March 30, 2026, against a prior closing price of $27.39 on March 27, 2026, implying a premarket price near $18.63. The primary catalyst is the release of topline Phase 3 REVEAL-1 clinical trial data for elegrobart (VRDN-003) in patients with active thyroid eye disease (TED), long anticipated as the company's most critical near-term de-risking event.
SYY shares are trading approximately -6.40% lower in premarket trading on March 30, 2026, from a prior close of $81.80 to roughly $76.56. The primary catalyst is Sysco's announcement of a $29.1 billion definitive agreement to acquire Jetro Restaurant Depot, one of the nation's largest Cash & Carry food wholesalers.
Northwest Biotherapeutics, Inc. (NWBO) is a clinical-stage biotechnology company focused on developing personalized immune therapies, primarily dendritic cell-based vaccines under its DCVax platform. The company's lead candidate, DCVax-L, targets glioblastoma multiforme (GBM), a lethal brain cancer, following completion of a Phase III trial. DCVax-Direct addresses inoperable solid tumors, with Phase I/II data available. NWBO operates in the competitive immunotherapy sector against players like large-cap biotechs, relying on a proprietary manufacturing process for cost-effective production.
FingerMotion, Inc. (FNGR) operates as a mobile data specialist, delivering mobile payment and recharge platform solutions mainly in China. The company's core revolves around telecommunication products and services, such as top-up recharges, data plans, SMS and MMS services, big data insights for consumer behavior analysis, and rich communication services (RCS) platforms. It also provides value-added products through partnerships with telecom providers and e-commerce platforms.
NIO Inc. (NIO) stands out as a leading Chinese electric vehicle manufacturer focused on premium smart EVs. The company designs, develops, and sells high-end battery electric vehicles, bolstered by its Battery-as-a-Service model that lets customers swap batteries at stations rather than owning them. In the cutthroat Chinese EV space, NIO competes directly with firms like XPEV and LI.
Xcel Energy Inc. (XEL) stands out as a major U.S. electric and natural gas utility, serving about 3.7 million electric and 2.2 million natural gas customers across eight states, mainly in the Midwest and West. The company focuses on regulated utilities, handling electricity generation, transmission, and distribution, while increasingly prioritizing renewable sources like wind and solar. Its model centers on steady, regulated returns from infrastructure investments, backed by rate cases and recovery mechanisms.
Occidental Petroleum Corporation (OXY) stands out as a leading independent energy producer, with a primary focus on hydrocarbon exploration and production. The company has significant operations in the Permian Basin, one of the U.S.'s most productive oil regions, along with assets in the Rockies, Latin America, and the Middle East. Its business model emphasizes efficient drilling, low-cost production, and carbon capture initiatives aimed at long-term sustainability.
The ProShares UltraShort Bloomberg Natural Gas (KOLD) is a leveraged inverse exchange-traded fund that seeks daily investment results, before fees and expenses, corresponding to two times the inverse (-2x) of the daily performance of the Bloomberg Natural Gas Subindex. This subindex reflects the natural gas segment of the commodities market by tracking futures contracts, primarily the second-month Henry Hub natural gas futures, weighted by liquidity and production. The fund does not invest directly in physical natural gas but uses derivatives like futures contracts and swaps to achieve its objective.
Shares of United Therapeutics (UTHR) are surging approximately +17% in premarket trading on Monday, March 30, 2026, with the market not yet open. The primary catalyst is a landmark Phase 3 clinical trial announcement: the TETON-1 pivotal study of nebulized Tyvaso® (treprostinil) met its primary endpoint for treating idiopathic pulmonary fibrosis (IPF), exceeding the already impressive treatment effects seen in the previously completed TETON-2 study.